Boston, MA -- (SBWIRE) -- 09/24/2014 -- Netscribes' latest market research report titled Clinical Trials Market in India 2014 analyses how India is a potential global hub for conducting clinical trials by Indian as well as global pharmaceutical companies. Clinical trials are conducted on humans to examine the efficacy and safety of new drugs, treatments, therapies and new medical devices before launching them in the market. It is a necessary and final step for the completion of the drug development process. The market is divided into four phases - Phase I, Phase II, Phase III and Phase IV. Contract Research Organizations (CROs) are responsible for designing, monitoring, and managing clinical trials. The market is dominated by private players and foreign pharmaceutical companies.

View Full Report Details and Table of Contents

The clinical research market in India has comparative advantage in conducting clinical trials regarding cost efficiency and a vast population suffering from acute chronic diseases. Government regulations regarding the compensation rule and approval time are hampering the market at present, but the situation is expected to improve soon. Apart from the pharma companies there are several research institutes involved in R&D of clinical trials. Increasing partnerships and changes in the regulatory environment are crucial future driving factors for this market.

Companies Mentioned in this Report: Private Companies, 1. Clininvent Research Pvt. Ltd., 2. SIRO Clinpharm Pvt. Ltd., 3. Sristek Clinical Research Solutions Ltd., 4. Synchron Research Services Pvt. Ltd., 5. Clintech Research India Pvt. Ltd., 6. ICON Clinical Research India Pvt. Ltd., 7. PAREXEL International (India) Pvt. Ltd., 8. Quintiles Research (India) Pvt. Ltd., , Research Organizations, 1. Advanced Centre for Treatment, Research and Education in Cancer, 2. Central Drug Research Institute (CDRI), 3. Institute of Cytology & Preventive Oncology, 4. National AIDS Research Institute, 5. National Brain Research Center, 6. National Institute of Cholera and Enteric Diseases, 7. National Institute of Immunology, 8. National Institute of Nutrition, 9. National Institute of Virology (NIV), 10. Tuberculosis Research Centre (TRC)

About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:

- Type 2 Diabetes Global Clinical Trials Review, H1, 2014
- Age Related Macular Degeneration Global Clinical Trials Review, H1, 2014
- Alzheimer's Disease Global Clinical Trials Review, H1, 2014
- Refractory Multiple Myeloma Global Clinical Trials Review, H1, 2014
- Metastatic Breast Cancer Global Clinical Trials Review, H1, 2014
- Amyotrophic Lateral Sclerosis Global Clinical Trials Review, H1, 2014
- T-Cell Lymphomas Global Clinical Trials Review, H1, 2014
- Indolent Lymphoma Global Clinical Trials Review, H1, 2014
- Metastatic Prostate Cancer Global Clinical Trials Review, H1, 2014
- B-Cell Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2014